Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.
about
Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapyTargeting MYC Dependence by Metabolic Inhibitors in CancerDichloroacetate induces autophagy in colorectal cancer cells and tumours.Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3.Rapid reduction in breast cancer mortality with inorganic arsenic in drinking waterDual-targeting of aberrant glucose metabolism in glioblastomaBoth GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells.Autophagy interplays with apoptosis and cell cycle regulation in the growth inhibiting effect of Trisenox in HEP-2, a laryngeal squamous cancer.Resveratrol protects against arsenic trioxide-induced oxidative damage through maintenance of glutathione homeostasis and inhibition of apoptotic progression.The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathwayMEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancerDichloroacetate, the Pyruvate Dehydrogenase Complex and the Modulation of mESC Pluripotency.Targeting of two aspects of metabolism in breast cancer treatment.Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.Targeting cancer cell mitochondria as a therapeutic approach.Long-term stabilization of stage 4 colon cancer using sodium dichloroacetate therapyRadiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer.Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model.Targeting mitochondrial function for the treatment of breast cancer.Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells.Cytotoxicity of Manganese (III) Complex in Human Breast Adenocarcinoma Cell Line Is Mediated by the Generation of Reactive Oxygen Species Followed by Mitochondrial Damage.Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer.Dichloroacetate inhibits aerobic glycolysis in multiple myeloma cells and increases sensitivity to bortezomib.PDK1 inhibition is a novel therapeutic target in multiple myelomaDichloroacetate Prevents Cisplatin-Induced Nephrotoxicity without Compromising Cisplatin Anticancer PropertiesLong-term stabilization of metastatic melanoma with sodium dichloroacetateEugenol inhibits oxidative phosphorylation and fatty acid oxidation via downregulation of c-Myc/PGC-1β/ERRα signaling pathway in MCF10A-ras cellsGlucose Metabolism in Cancer and Ischemia: Possible Therapeutic Consequences of the Warburg Effect.Activation of the Nrf2 Signaling Pathway Involving KLF9 Plays a Critical Role in Allicin Resisting Against Arsenic Trioxide-Induced Hepatotoxicity in Rats.
P2860
Q26823022-A1F7B648-35D0-410B-B8AC-7AEB6DD71443Q33608493-4691D737-F6C2-458E-8427-2844D8079D5EQ33918095-290849DD-E3E6-4825-A11D-55CECD23DC6BQ34100963-92BF63A5-4C4D-4F0E-93FD-670A2B164D34Q34866709-93832F25-D4FE-48DA-8295-BB5717903671Q35073645-9EED881B-79C5-4FA2-AF21-058C648CD320Q35083218-DC3DC506-DC91-47A3-8F88-B4FBE00C684DQ35170531-06C67D62-C751-452B-966C-A5382A9D4FEBQ35224476-0106EA84-2633-4B37-A3B3-5B1F9A71B5DEQ35273665-FAADBE44-3DBF-4AF0-9D31-BEB7E15D65E6Q35450566-7246392B-6A37-468E-AD38-5EBBB0EB1EEBQ35567679-CEE9399D-A194-4AD4-83B6-A78D4D80AB22Q35683716-BBD7A15A-252B-4D30-AF62-2025E37EB4F5Q36213008-109A3E0A-0003-48EA-AA6B-5E48B20A01CDQ36557906-D0C8EBE7-28EF-4B8C-8860-E78219CCEE98Q36655323-EE098F40-3B2D-4CED-9F3C-BB3C1EA4A2FEQ37345346-20D65502-CE9F-4C24-B09A-AA9EA4D29AC9Q37520289-75E20A67-ABDB-4A82-882E-5AFD588970FDQ37662302-ECC26B16-468F-41CF-ABDB-EC9E502A5223Q38264534-915A65D5-7144-460D-A17C-928938B3C7BDQ38711927-9EEF1392-9D96-4E1D-A29C-14E16742E084Q38755537-3400BF0B-9D05-4544-BBC9-5D93693431FAQ38874710-C79F89EE-7FE3-450F-B3AA-A7170BAE9B22Q38995243-75190C27-3604-4B18-8431-1F8207543D2DQ39175249-3FB59AEA-F92B-457E-BEB0-00BCCE352568Q39210001-6310FCE9-838B-4E78-8F4C-978DAFC6BD8EQ39933592-DBA9D509-1E5A-4F50-BFD2-87E866AAB235Q41374660-95EB374B-F190-4B19-8353-5DDB75929F71Q42374192-388518A6-C35E-4D5F-956C-461D0AC0CF09Q47996619-51C313FB-C792-4283-9427-5111A8C41F2AQ51550506-E4302653-3948-4736-9C76-2592305F83DD
P2860
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.
@ast
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.
@en
type
label
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.
@ast
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.
@en
prefLabel
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.
@ast
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.
@en
P2860
P356
P1433
P1476
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
@en
P2093
Philip G Board
Ramon C Sun
P2860
P2888
P356
10.1186/1476-4598-10-142
P577
2011-11-18T00:00:00Z
P5875
P6179
1044062548